Opioid Innovation Fund

Created by Executive Vice President and Provost Bruce A. McPheron in October 2017, the fund has distributed nearly $1 million to 16 teams over two rounds. Projects serve one of two goals: to develop products that community partners can use right away or to answer research questions that inform the scientific community, practitioners and policymakers.

“Because of the scope of the university’s disciplines and resources, and because of the partnerships we’ve formed over the years throughout the state, we are well suited to attack the many problems associated with addiction,” said William J. Martin, dean of the College of Public Health, which administers the fund. “The Opioid Innovation Fund connects creative minds to help us do that and squarely aligns with our land grant mission.”

According to the most recent statistics from the Centers for Disease Control and Prevention, 4,293 Ohioans died from opioid-related overdoses in 2017. That breaks down to 39.2 opioid-related overdose deaths per 100,000 people, a rate that is second only to West Virginia.

The Wexner Medical Center, Ohio State Extension and colleges throughout the university are all involved in addressing the substance abuse and the opioid crisis. Last month, the National Institutes of Health awarded a $65.9 million grant to Ohio State to lead a statewide consortium charged with reducing opioid overdose deaths by 40% over three years. The award for HEALing Communities Study is the university’s largest research grant ever.

Details of the 2019-20 Opioid Innovation Fund application process have not yet been announced. Information will be posted on this webpage and announced in publications such as onCampus when available. For information about how the last round of funding worked, view the second round funding instructions. Procedures may change in the next round of funding. 

Frequently Asked Questions

We anticipate that a second round of applications for OIF support will be due in fall 2018. Details will be posted here, on the Opioid Innovation Fund webpage, as they become available. Look for announcements in OnCampus and other university news outlets as we get closer to the date.

Eighty-nine pre-proposals were submitted, and 32 were recommended for final submission. Twenty-eight were ultimately submitted. From this group, two proposals were chosen for implementation grants of up to $100,000, and six for planning grants of up to $50,000.

A panel of several independent reviewers evaluated and ranked the proposals. The review followed the traditional NIH review format and used the 1-9 scale of ranking.

All of the submissions reflected innovative ideas, but the selected proposals were notable because they addressed an important need related to the opioid crisis and offered a clear plan for evaluation of the project and its potential for broader implementation.

We are dedicated to helping develop the many innovative ideas that were not funded in the first round. The OIF Grant Support Team will be hosting a grant development workshop prior to the next submission deadline. Please watch the OIF webpage and OnCampus for dates.

Yes!  The principal investigators on each grant will be receiving reviewer feedback via email.

Grant guidelines and the application timeline for the first round of funding in March 2018 remain published online and are accesible using the link immediately below. It’s possible that guidelines might be revised in some fashion for the second round.

Contact the Opioid Innovation Fund at CPH-OIFGrants@osu.edu.

Previous Grant Recipients

2018-19 Recipients